Spencer Ng, B.Sc.^*, Jiusheng Deng, PhD^*, Raghavan Chinndurai, PhD^*, Shala Yuan, MS^*, Andrea Pennati, PhD^* and Jacques Galipeau, MD

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA

Kankana Bardhan, PhD^*, Nikolaos Patsoukis, PhD^*, Alexandra Plessa^*, Niko Tsopoulidis^*, Duygu Sari^*, Lequn Li, MD, PhD^* and Vassiliki A. Boussiotis, MD, PhD

Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Janna Rudolph^1*, Annkristin Heine, MD^2*, Thomas Quast^3*, Waldemar Kolanus^3*, Peter Brossart, MD¹ and Dominik Wolf, MD^2*

¹Department of Internal Medicine III, Oncology, Hematology and Rheumatology, University Clinic Bonn, Bonn, Germany
²Department of Internal Medicine III, Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany
³Molecular Immunology & Cell Biology, Life and Medical Sciences Institute (LIMES), University Bonn, Bonn, Germany

Norihiro Ueda, MD^1,2,3*, Yasusi Uemura, PhD^2,4*, Rhong Zhang, MD, PhD^2,4*, Shuichi Kitayama^3*, Yutaka Yasui^3*, Minako Tatsumi^2*, Tian-Yi Liu, MD, PhD^2,5*, Kiyotaka Kuzushima, MD, PhD^2*, Hitoshi Kiyoi, MD, PhD⁶, Tomoki Naoe, MD, Ph.D.⁷ and Shin Kaneko, MD, PhD^3*

¹Department of Hematology and Oncology, Nagoya University, Nagoya, Japan
²Division of Immunology, Aichi Cancer Center Research Institute, Nagoya, Japan
³Center of iPS cell Research and Application, Kyoto University, Kyoto, Japan
⁴Division of Cancer Immunotherapy, National Cancer Center, Kashiwa, Japan
⁵Department of Oncology, Chinese PLA General Hospital, Beijing, China
⁶Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
⁷National Hospital Organization Nagoya Medical Center, Nagoya, Japan

Masahiro Hirakawa, MD, PhD^1*, Tiago R Matos, MD, MSc^1*, Edouard Forcade, MD^1*, Kathy S. Wang, PhD¹, Eduardo L Espada, MD^1*, Jennifer Whangbo, MD, PhD², Carol G Reynolds, PhD^2*, Marie J Chammas^2*, Kazuyuki Murase, MD, PhD^1,3 and Jerome Ritz, MD²

¹Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
³Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan

Fang Fang^*, Mangju Wang, MD^*, Quan Qiu^*, Dingfang Bu^*, Wei Liu, MD^*, Ying Zhang^*, Yongjin Shi^*, Xuzhen Lv^* and Ping Zhu, MD

Department of Hematology, Peking University First Hospital, Beijing, China

Meghali Goswami^1,2, Gabrielle T. Prince, MD³, Angelique Biancotto, PhD^4*, Susan Moir, PhD^5*, Foo Cheung, PhD^4*, Yuri Kotliarov, PhD^4*, Kimberly Dunham^6*, Jinguo Chen, MD^4*, Rongye Shi, MD^4*, Huizhi Zhou^4*, Hana Golding, PhD^7*, Jingrong Tang, MD, PhD^8*, John S. Tsang, PhD^4,9*, Howard B. Dickler, MD^4*, Kimberly Noonan, PhD, MPH^3*, B. Douglas Smith, MD¹⁰, Ivan M. Borrello, MD¹¹ and Christopher S. Hourigan, MD, PhD^1,4

¹Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
²The Institute for Biomedical Sciences, The George Washington University, Washington, DC
³Johns Hopkins School of Medicine, Baltimore, MD
⁴Center for Human Immunology, Autoimmunity, and Inflammation, National Institutes of Health, Bethesda, MD
⁵Immunopathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
⁶National Cancer Institute, Leidos Biomedical Research Inc., Frederick, MD
⁷Food and Drug Administration, Silver Spring, MD
⁸Myeloid Malignancies Section, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
⁹Systems Genomics and Bioinformatics Unit, Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
¹⁰Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
¹¹Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD

Van Hung Tran, PhD^1*, Florence Persat, MD^2*, Sophie Gardes, MD^3*, Jeremy Monfray, CRA^4*, Sophie Ducastelle-Leprêtre, MD^4*, Damien Dupont^2*, Mohamad Sobh, PharmD^4*, Fiorenza Barraco, MD^4*, Hélène Labussière-Wallet, MD^4*, Xavier Thomas⁴, Franck E. Nicolini, MD, PhD⁴, Caroline Lejeune, MD^4*, Marie Balsat, MD^4*, René Ecochard, MD, PhD^1* and Mauricette Michallet, MD, PhD⁴

¹CNRS, UMR 5558, Equipe Biostatistique Santé, Laboratoire de Biométrie et Biologie Evolutive, Université Claude Bernard Lyon I, Villeurbanne, France
²Institut de Parasitologie et Mycologie Médicale, Hôpital de la Croix-Rousse, Lyon, France
³Service Hygiène Hospitalière, Centre Hospitalier Lyon Sud, Pierre Bénite, France
⁴Hematology department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France

Amal J. Ali^1*, Jasmeen S. Merzaban, PhD² and Ayman F. Abuelela^2*

¹BIOLOGICAL AND ENVIRONMENTAL SCIENCE AND ENGINEERING, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
²Division of Biological and Environmental Sciences & Engineering, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia

Sebastien Viel^1*, Laurie Besson^2*, Emily Charrier^1*, Jacques Bienvenu^1*, Emmanuel Disse^1*, Thierry Walzer^2* and Charles Dumontet¹

¹HCL, Lyon, France
²INSERM, Lyon, France

Lijun Meng^1*, Zhenjiang Bai^2*, Shan He³, Kazuhiro Mochizuki, MD, PhD^4*, Janaki Purushe^5*, Hongxing Sun^5*, Jian Wang^2*, Hideo Yagita, PhD^6*, Shin Mineishi, MD⁷, Henry Fung^8*, Gregory A. Yanik, MD^9*, Roberto Caricchio^1*, Xiaoxuan Fan^1*, Lisa M Crisalli^10*, Ran Reshef, MD¹¹, Yanyun Zhang^12* and Yi Zhang^3,13

¹Temple University, Philadelphia, PA
²Soochow University, Suzhou, China
³Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA
⁴Department of Pediatric Oncology, Fukushima Medical University, Fukushima, Japan
⁵Temple University, Philadelphia
⁶Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan
⁷University of Alabama at Birmingham, Birmingham, AL
⁸Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA
⁹Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI
¹⁰University of Pennsylvania, Philadelphia
¹¹Columbia University Medical Center, New York, NY
¹²Shanghai Institutes For Biological Science, Shanghai, China
¹³Department of Microbiology and Immunology, Temple University, Philadelphia, PA

Alexander Shimabukuro-Vornhagen, MD^1*, María Alejandra García-Márquez, PhD^2*, Rieke N. Fischer^2*, Juliane Iltgen-Breburda^3*, Anne Fiedler^3*, Kerstin Wennhold, PhD^3*, Gunter Rappl^4*, Hinrich Abken^4*, Pia Hartmann^2*, Clara Lehmann^2*, Thomas Koslowsky^5*, Marco Herling, MD^6*, Dirk Beutner^3*, Dominik Wolf, MD^7*, Gerd Fätkenheuer^3*, Andrea Rubbert-Roth^3*, Michael Hallek, MD⁸, Sebastian Theurich^9* and Michael von Bergwelt-Baildon, Prof. Dr. Dr.^3*

¹Department I of Internal Medicine, Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Cologne, Germany
²Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
³University Hospital of Cologne, Cologne, Germany
⁴Centre for Molecular Medicine Cologne, University Hospital of Cologne, Cologne, Germany
⁵St. Elizabeth-Krankenhaus Köln-Hohenlind, Cologne, Germany
⁶CECAD and Dept. of Medicine I Cologne University, Cologne, Germany
⁷Department of Internal Medicine III, Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany
⁸Department of Internal Medicine, University of Cologne, Cologne, Germany
⁹Internal Med., Cologne, Germany

Asen Bagashev, PhD^1*, Elena Sotillo, PhD^2*, Glendon Wu^3* and Andrei Thomas-Tikhonenko, PhD⁴

¹Division of Cancer Pathobiology, The Children's Hospital of Philadelphia, Philadelphia, PA
²Cancer Pathobiology, The Children's Hospital of Philadelphia, Philadelphia, PA
³Perelman School of Medicine at the University of Pennsylvania, Philadelphia
⁴Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA

Katja G. Weinacht, MD, PhD¹, Louis m Charbonnier, PhD^2*, Ashley Plant, MD^3*, Troy Torgerson, MD, PhD^4,5*, Sergei Rosenzweig, MD, PhD^6*, Thomas Fleisher, MD, PhD^7* and Luigi Daniele Notarangelo, MD^8*

¹Hematology/Oncology, Children's Hospital Boston/Dana-Farber Cancer Institute, Boston, MA
²Department of Pediatric Immunology, Boston Children's Hospital, Boston
³department of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston
⁴University of Washington, Seattle, WA
⁵Seattle Children's Research Institute, Seattle, WA
⁶NIAID, NIH, Bethesda
⁷NCI/NIAID/Laboratory Medicine, NIH, Bethesda
⁸Division of Immunology, Boston Children's Hospital, Boston, MA

Dan Li, Ph.D.¹, Patenia Rebecca, BS^1*, Roza Nurieva, PhD^2*, Jeffrey J. Molldrem, MD¹, Richard E. Champlin, MD¹ and Qing Ma, PhD¹

¹Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX
²Immunology, University of Texas M.D. Anderson Cancer Center, Houston, TX

Simon Heidegger, MD^1*, Diana Kreppel^1*, Michael Bscheider, MD^2*, Alexander Wintges^1*, Sarah Bek^1*, Martina Schmickl^1*, Jürgen Ruland, MD^3*, Christian Peschel, MD¹, Marcel van den Brink, MD^4*, Tobias Haas, MD^1* and Hendrik Poeck, MD^1,4*

¹III. Medizinische Klinik, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
²Laboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, California, USA, Stanford, CA
³Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
⁴Memorial Sloan Kettering Cancer Center, New York, NY

Amanda L Richards^1*, James C. Zimring, MD, PhD^1,2 and Krystalyn E. Hudson, PhD¹

¹BloodworksNW Research Institute, Seattle, WA
²Department of Laboratory Medicine and Division of Hematology, University of Washington, Seattle, WA

Jingxia Li^1,2*, Reema Panjwani^1*, Jian-Ming Li, Ph.D³, Cynthia R. Giver, PhD⁴, Maryellen Malone^1* and Edmund K Waller, MD, PhD⁴

¹Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
²Xiangya Hospital, Central South University, Changsha, China
³Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
⁴Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA

Xing Zhao, Ph.D^1,2*, Narendiran Rajasekaran, PhD^1*, Cariad Chester, BA^1*, Atsushi Yonezawa, PhD^1,3*, Suparna Dutt, PhD⁴, Matt Coffey^5*, Zhixu He, MD, PhD^6* and Holbrook E Kohrt, MD, Ph.D.¹

¹Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
²Department of Immunology, Guizhou Medical University, Guiyang, China
³Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital,, Kyoto, Japan
⁴Stanford University School of Medicine, Stanford, CA
⁵Oncolytics Biotech, Calgary, Canada
⁶Tissue Engineering and Stem Cell Research Center, Guiyang Medical University, Guiyang, China

Rebecca S Hesterberg, BA^1,2 and Pearlie K Epling-Burnette, PharmD PhD³

¹Cancer Biology PhD Program, University of South Florida, Tampa, FL
²Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Immunology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Sut Ling Wong, Ph.D.¹, Amanda L Richards^1*, James C. Zimring, MD, PhD^1,2 and Krystalyn E. Hudson, PhD¹

¹BloodworksNW Research Institute, Seattle, WA
²Department of Laboratory Medicine and Division of Hematology, University of Washington, Seattle, WA